nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—nerve—acquired immunodeficiency syndrome	0.00764	0.0464	CbGeAlD
Methysergide—HTR7—endothelium—acquired immunodeficiency syndrome	0.0065	0.0395	CbGeAlD
Methysergide—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00604	0.0367	CbGeAlD
Methysergide—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00577	0.0351	CbGeAlD
Methysergide—HTR1F—nervous system—acquired immunodeficiency syndrome	0.00544	0.033	CbGeAlD
Methysergide—HTR1F—central nervous system—acquired immunodeficiency syndrome	0.00523	0.0318	CbGeAlD
Methysergide—HTR2A—nerve—acquired immunodeficiency syndrome	0.00476	0.0289	CbGeAlD
Methysergide—HTR1E—nervous system—acquired immunodeficiency syndrome	0.00471	0.0286	CbGeAlD
Methysergide—HTR1E—central nervous system—acquired immunodeficiency syndrome	0.00453	0.0275	CbGeAlD
Methysergide—HTR1F—brain—acquired immunodeficiency syndrome	0.00415	0.0252	CbGeAlD
Methysergide—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00405	0.0246	CbGeAlD
Methysergide—HTR6—nervous system—acquired immunodeficiency syndrome	0.00369	0.0224	CbGeAlD
Methysergide—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.0036	0.0219	CbGeAlD
Methysergide—HTR1E—brain—acquired immunodeficiency syndrome	0.0036	0.0218	CbGeAlD
Methysergide—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00356	0.0216	CbGeAlD
Methysergide—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00324	0.0197	CbGeAlD
Methysergide—HTR6—brain—acquired immunodeficiency syndrome	0.00282	0.0171	CbGeAlD
Methysergide—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00264	0.016	CbGeAlD
Methysergide—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00259	0.0157	CbGeAlD
Methysergide—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00253	0.0154	CbGeAlD
Methysergide—SIGMAR1—blood—acquired immunodeficiency syndrome	0.00248	0.015	CbGeAlD
Methysergide—HTR2B—blood—acquired immunodeficiency syndrome	0.00247	0.015	CbGeAlD
Methysergide—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.0024	0.0145	CbGeAlD
Methysergide—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.00239	0.0145	CbGeAlD
Methysergide—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.0023	0.0139	CbGeAlD
Methysergide—HTR2B—vagina—acquired immunodeficiency syndrome	0.00229	0.0139	CbGeAlD
Methysergide—HTR1B—nervous system—acquired immunodeficiency syndrome	0.00223	0.0135	CbGeAlD
Methysergide—HTR7—digestive system—acquired immunodeficiency syndrome	0.00222	0.0135	CbGeAlD
Methysergide—SIGMAR1—lung—acquired immunodeficiency syndrome	0.00217	0.0132	CbGeAlD
Methysergide—HTR2B—lung—acquired immunodeficiency syndrome	0.00217	0.0131	CbGeAlD
Methysergide—HTR1D—nervous system—acquired immunodeficiency syndrome	0.00216	0.0131	CbGeAlD
Methysergide—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.00214	0.013	CbGeAlD
Methysergide—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00213	0.013	CbGeAlD
Methysergide—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.00213	0.0129	CbGeAlD
Methysergide—HTR7—blood—acquired immunodeficiency syndrome	0.00212	0.0128	CbGeAlD
Methysergide—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.00208	0.0126	CbGeAlD
Methysergide—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00206	0.0125	CbGeAlD
Methysergide—HTR7—spinal cord—acquired immunodeficiency syndrome	0.00204	0.0124	CbGeAlD
Methysergide—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00201	0.0122	CbGeAlD
Methysergide—HTR2A—retina—acquired immunodeficiency syndrome	0.00197	0.012	CbGeAlD
Methysergide—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00193	0.0117	CbGeAlD
Methysergide—HTR7—lung—acquired immunodeficiency syndrome	0.00185	0.0113	CbGeAlD
Methysergide—HTR1A—nervous system—acquired immunodeficiency syndrome	0.0018	0.0109	CbGeAlD
Methysergide—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00173	0.0105	CbGeAlD
Methysergide—HTR7—nervous system—acquired immunodeficiency syndrome	0.00172	0.0104	CbGeAlD
Methysergide—HTR1B—brain—acquired immunodeficiency syndrome	0.0017	0.0103	CbGeAlD
Methysergide—HTR7—central nervous system—acquired immunodeficiency syndrome	0.00165	0.01	CbGeAlD
Methysergide—HTR1D—brain—acquired immunodeficiency syndrome	0.00165	0.01	CbGeAlD
Methysergide—HTR2C—brain—acquired immunodeficiency syndrome	0.00163	0.00991	CbGeAlD
Methysergide—SIGMAR1—brain—acquired immunodeficiency syndrome	0.00154	0.00933	CbGeAlD
Methysergide—HTR2B—brain—acquired immunodeficiency syndrome	0.00153	0.00931	CbGeAlD
Methysergide—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.00148	0.00901	CbGeAlD
Methysergide—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00148	0.00899	CbGeAlD
Methysergide—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00138	0.00841	CbGeAlD
Methysergide—HTR1A—brain—acquired immunodeficiency syndrome	0.00137	0.00834	CbGeAlD
Methysergide—Pain—Abacavir—acquired immunodeficiency syndrome	0.00133	0.00208	CcSEcCtD
Methysergide—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Methysergide—HTR2A—blood—acquired immunodeficiency syndrome	0.00132	0.00801	CbGeAlD
Methysergide—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00206	CcSEcCtD
Methysergide—HTR7—brain—acquired immunodeficiency syndrome	0.00131	0.00797	CbGeAlD
Methysergide—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00205	CcSEcCtD
Methysergide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00131	0.00204	CcSEcCtD
Methysergide—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.0013	0.00203	CcSEcCtD
Methysergide—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.0013	0.00203	CcSEcCtD
Methysergide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.0013	0.00203	CcSEcCtD
Methysergide—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00129	0.00202	CcSEcCtD
Methysergide—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00201	CcSEcCtD
Methysergide—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.00201	CcSEcCtD
Methysergide—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.002	CcSEcCtD
Methysergide—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00128	0.002	CcSEcCtD
Methysergide—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.002	CcSEcCtD
Methysergide—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00199	CcSEcCtD
Methysergide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00127	0.00199	CcSEcCtD
Methysergide—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00127	0.00772	CbGeAlD
Methysergide—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00198	CcSEcCtD
Methysergide—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Methysergide—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Methysergide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Methysergide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Methysergide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00126	0.00197	CcSEcCtD
Methysergide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00126	0.00196	CcSEcCtD
Methysergide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00126	0.00196	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Methysergide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Methysergide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Methysergide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Methysergide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00125	0.00195	CcSEcCtD
Methysergide—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00195	CcSEcCtD
Methysergide—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00195	CcSEcCtD
Methysergide—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00193	CcSEcCtD
Methysergide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00123	0.00193	CcSEcCtD
Methysergide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00123	0.00193	CcSEcCtD
Methysergide—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00192	CcSEcCtD
Methysergide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Methysergide—HTR2A—vagina—acquired immunodeficiency syndrome	0.00122	0.00742	CbGeAlD
Methysergide—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Methysergide—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Methysergide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.0019	CcSEcCtD
Methysergide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00121	0.00189	CcSEcCtD
Methysergide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00189	CcSEcCtD
Methysergide—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00189	CcSEcCtD
Methysergide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00189	CcSEcCtD
Methysergide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00186	CcSEcCtD
Methysergide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00119	0.00186	CcSEcCtD
Methysergide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00186	CcSEcCtD
Methysergide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00185	CcSEcCtD
Methysergide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00185	CcSEcCtD
Methysergide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00185	CcSEcCtD
Methysergide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00184	CcSEcCtD
Methysergide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00184	CcSEcCtD
Methysergide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00184	CcSEcCtD
Methysergide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00184	CcSEcCtD
Methysergide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00183	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00182	CcSEcCtD
Methysergide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00182	CcSEcCtD
Methysergide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Methysergide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Methysergide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00181	CcSEcCtD
Methysergide—HTR2A—lung—acquired immunodeficiency syndrome	0.00116	0.00702	CbGeAlD
Methysergide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Methysergide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Methysergide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00115	0.0018	CcSEcCtD
Methysergide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00178	CcSEcCtD
Methysergide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00177	CcSEcCtD
Methysergide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00177	CcSEcCtD
Methysergide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00176	CcSEcCtD
Methysergide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00113	0.00176	CcSEcCtD
Methysergide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00176	CcSEcCtD
Methysergide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00112	0.00175	CcSEcCtD
Methysergide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00175	CcSEcCtD
Methysergide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00175	CcSEcCtD
Methysergide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00174	CcSEcCtD
Methysergide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00174	CcSEcCtD
Methysergide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00174	CcSEcCtD
Methysergide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00173	CcSEcCtD
Methysergide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Methysergide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00172	CcSEcCtD
Methysergide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Methysergide—Pain—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Methysergide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Methysergide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00171	CcSEcCtD
Methysergide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00109	0.0017	CcSEcCtD
Methysergide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00109	0.0017	CcSEcCtD
Methysergide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00109	0.0017	CcSEcCtD
Methysergide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.0017	CcSEcCtD
Methysergide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.0017	CcSEcCtD
Methysergide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Methysergide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00108	0.00169	CcSEcCtD
Methysergide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00168	CcSEcCtD
Methysergide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00168	CcSEcCtD
Methysergide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Methysergide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Methysergide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Methysergide—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00107	0.0065	CbGeAlD
Methysergide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00167	CcSEcCtD
Methysergide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00107	0.00167	CcSEcCtD
Methysergide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00166	CcSEcCtD
Methysergide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00166	CcSEcCtD
Methysergide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00165	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00165	CcSEcCtD
Methysergide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Methysergide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Methysergide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Methysergide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Methysergide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00164	CcSEcCtD
Methysergide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Methysergide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Methysergide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Methysergide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Methysergide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00163	CcSEcCtD
Methysergide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00162	CcSEcCtD
Methysergide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00162	CcSEcCtD
Methysergide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00162	CcSEcCtD
Methysergide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00162	CcSEcCtD
Methysergide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00161	CcSEcCtD
Methysergide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00161	CcSEcCtD
Methysergide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00161	CcSEcCtD
Methysergide—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00103	0.00626	CbGeAlD
Methysergide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00161	CcSEcCtD
Methysergide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00161	CcSEcCtD
Methysergide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.0016	CcSEcCtD
Methysergide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.0016	CcSEcCtD
Methysergide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.0016	CcSEcCtD
Methysergide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00159	CcSEcCtD
Methysergide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00158	CcSEcCtD
Methysergide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00158	CcSEcCtD
Methysergide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00158	CcSEcCtD
Methysergide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00158	CcSEcCtD
Methysergide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00158	CcSEcCtD
Methysergide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00157	CcSEcCtD
Methysergide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.001	0.00156	CcSEcCtD
Methysergide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.001	0.00156	CcSEcCtD
Methysergide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000999	0.00156	CcSEcCtD
Methysergide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000999	0.00156	CcSEcCtD
Methysergide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000998	0.00156	CcSEcCtD
Methysergide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000998	0.00156	CcSEcCtD
Methysergide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000997	0.00156	CcSEcCtD
Methysergide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000992	0.00155	CcSEcCtD
Methysergide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00099	0.00155	CcSEcCtD
Methysergide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00099	0.00155	CcSEcCtD
Methysergide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000989	0.00155	CcSEcCtD
Methysergide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000988	0.00154	CcSEcCtD
Methysergide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000984	0.00154	CcSEcCtD
Methysergide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000983	0.00154	CcSEcCtD
Methysergide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000983	0.00154	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000975	0.00152	CcSEcCtD
Methysergide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000974	0.00152	CcSEcCtD
Methysergide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000968	0.00151	CcSEcCtD
Methysergide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000962	0.0015	CcSEcCtD
Methysergide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000961	0.0015	CcSEcCtD
Methysergide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000956	0.00149	CcSEcCtD
Methysergide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000956	0.00149	CcSEcCtD
Methysergide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000954	0.00149	CcSEcCtD
Methysergide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000954	0.00149	CcSEcCtD
Methysergide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000951	0.00149	CcSEcCtD
Methysergide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000946	0.00148	CcSEcCtD
Methysergide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000944	0.00147	CcSEcCtD
Methysergide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000942	0.00147	CcSEcCtD
Methysergide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000942	0.00147	CcSEcCtD
Methysergide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000941	0.00147	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000938	0.00147	CcSEcCtD
Methysergide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000932	0.00146	CcSEcCtD
Methysergide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000927	0.00145	CcSEcCtD
Methysergide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000925	0.00145	CcSEcCtD
Methysergide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000924	0.00144	CcSEcCtD
Methysergide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000923	0.00144	CcSEcCtD
Methysergide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000918	0.00144	CcSEcCtD
Methysergide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000918	0.00143	CcSEcCtD
Methysergide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000916	0.00143	CcSEcCtD
Methysergide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.00143	CcSEcCtD
Methysergide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.00143	CcSEcCtD
Methysergide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000915	0.00143	CcSEcCtD
Methysergide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000915	0.00143	CcSEcCtD
Methysergide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00091	0.00142	CcSEcCtD
Methysergide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000907	0.00142	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000895	0.0014	CcSEcCtD
Methysergide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000889	0.00139	CcSEcCtD
Methysergide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000889	0.00139	CcSEcCtD
Methysergide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000888	0.00139	CcSEcCtD
Methysergide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000882	0.00138	CcSEcCtD
Methysergide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000882	0.00138	CcSEcCtD
Methysergide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.00138	CcSEcCtD
Methysergide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.00138	CcSEcCtD
Methysergide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000876	0.00137	CcSEcCtD
Methysergide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000876	0.00137	CcSEcCtD
Methysergide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000875	0.00137	CcSEcCtD
Methysergide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000875	0.00137	CcSEcCtD
Methysergide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000874	0.00136	CcSEcCtD
Methysergide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000868	0.00136	CcSEcCtD
Methysergide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000868	0.00136	CcSEcCtD
Methysergide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000867	0.00135	CcSEcCtD
Methysergide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000865	0.00135	CcSEcCtD
Methysergide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000849	0.00133	CcSEcCtD
Methysergide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000848	0.00133	CcSEcCtD
Methysergide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000847	0.00132	CcSEcCtD
Methysergide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000847	0.00132	CcSEcCtD
Methysergide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000846	0.00132	CcSEcCtD
Methysergide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000846	0.00132	CcSEcCtD
Methysergide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000842	0.00132	CcSEcCtD
Methysergide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.00131	CcSEcCtD
Methysergide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.00131	CcSEcCtD
Methysergide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00083	0.0013	CcSEcCtD
Methysergide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000828	0.00129	CcSEcCtD
Methysergide—HTR2A—brain—acquired immunodeficiency syndrome	0.000819	0.00497	CbGeAlD
Methysergide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000818	0.00128	CcSEcCtD
Methysergide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000814	0.00127	CcSEcCtD
Methysergide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000814	0.00127	CcSEcCtD
Methysergide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000814	0.00127	CcSEcCtD
Methysergide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00081	0.00127	CcSEcCtD
Methysergide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000807	0.00126	CcSEcCtD
Methysergide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000806	0.00126	CcSEcCtD
Methysergide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000803	0.00126	CcSEcCtD
Methysergide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.0008	0.00125	CcSEcCtD
Methysergide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000792	0.00124	CcSEcCtD
Methysergide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000777	0.00121	CcSEcCtD
Methysergide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000777	0.00121	CcSEcCtD
Methysergide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000769	0.0012	CcSEcCtD
Methysergide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000768	0.0012	CcSEcCtD
Methysergide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000765	0.0012	CcSEcCtD
Methysergide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000763	0.00119	CcSEcCtD
Methysergide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000762	0.00119	CcSEcCtD
Methysergide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00076	0.00119	CcSEcCtD
Methysergide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000739	0.00115	CcSEcCtD
Methysergide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000736	0.00115	CcSEcCtD
Methysergide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000732	0.00114	CcSEcCtD
Methysergide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00073	0.00114	CcSEcCtD
Methysergide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000729	0.00114	CcSEcCtD
Methysergide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.00112	CcSEcCtD
Methysergide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000708	0.00111	CcSEcCtD
Methysergide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000705	0.0011	CcSEcCtD
Methysergide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000705	0.0011	CcSEcCtD
Methysergide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.00107	CcSEcCtD
Methysergide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000681	0.00106	CcSEcCtD
Methysergide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00068	0.00106	CcSEcCtD
Methysergide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000675	0.00105	CcSEcCtD
Methysergide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000674	0.00105	CcSEcCtD
Methysergide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000672	0.00105	CcSEcCtD
Methysergide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000655	0.00102	CcSEcCtD
Methysergide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00065	0.00102	CcSEcCtD
Methysergide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000649	0.00101	CcSEcCtD
Methysergide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000649	0.00101	CcSEcCtD
Methysergide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000636	0.000993	CcSEcCtD
Methysergide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.000976	CcSEcCtD
Methysergide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00062	0.000968	CcSEcCtD
Methysergide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000619	0.000967	CcSEcCtD
Methysergide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.000956	CcSEcCtD
Methysergide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000584	0.000912	CcSEcCtD
Methysergide—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000195	0.000998	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000195	0.000997	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000195	0.000997	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000194	0.000995	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000194	0.000994	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000193	0.000991	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000193	0.000991	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000193	0.000991	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000193	0.000991	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000193	0.00099	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000191	0.000977	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00019	0.000973	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000189	0.00097	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000189	0.00097	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000189	0.000969	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000188	0.000964	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000188	0.000964	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000188	0.000963	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000187	0.000957	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000183	0.000937	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000182	0.00093	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000182	0.00093	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00018	0.000922	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00018	0.000922	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00018	0.000921	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000179	0.000915	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000178	0.000911	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000178	0.000911	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000178	0.000909	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000177	0.000906	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000177	0.000906	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000177	0.000905	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000177	0.000905	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000176	0.0009	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000176	0.0009	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000175	0.000896	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000175	0.000896	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000174	0.000892	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000173	0.000884	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000172	0.000881	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000172	0.000881	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000172	0.00088	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000169	0.000864	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000168	0.000859	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000164	0.000841	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000163	0.000834	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000162	0.000831	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000162	0.000831	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000162	0.000827	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000162	0.000827	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000154	0.000789	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000153	0.000786	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000153	0.000785	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000153	0.000784	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000153	0.000784	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000153	0.000782	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000151	0.000774	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.00015	0.000769	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000148	0.000759	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000148	0.000759	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000147	0.000755	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000147	0.000755	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000147	0.000754	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000147	0.000751	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000147	0.000751	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000146	0.000748	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000146	0.000747	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000146	0.000747	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000145	0.000742	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000144	0.000739	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000144	0.000739	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000144	0.000738	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000144	0.000735	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000144	0.000735	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000142	0.000727	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000139	0.000714	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000139	0.00071	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000136	0.000698	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000135	0.000693	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000135	0.00069	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000135	0.000689	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000134	0.000684	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000134	0.000684	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000133	0.000683	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000133	0.000683	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000133	0.000682	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000133	0.000682	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000133	0.000679	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000133	0.000679	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000133	0.000679	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000133	0.000679	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000132	0.000679	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000132	0.000674	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000131	0.000671	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000131	0.000671	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000131	0.00067	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00013	0.000668	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00013	0.000668	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00013	0.000666	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00013	0.000665	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000129	0.00066	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000127	0.000652	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000127	0.000652	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000125	0.000638	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000125	0.000638	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000123	0.000632	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000123	0.00063	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000123	0.000629	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000123	0.000629	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000122	0.000625	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000122	0.000624	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000122	0.000623	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000121	0.000621	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000121	0.000621	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000121	0.00062	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00012	0.000617	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00012	0.000617	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00012	0.000613	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000119	0.000612	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000118	0.000604	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000118	0.000603	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000116	0.000596	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000115	0.00059	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000115	0.000587	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00058	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00058	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000113	0.000579	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000112	0.000575	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000111	0.00057	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000111	0.00057	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000111	0.000569	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000111	0.000567	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00011	0.000565	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00011	0.000562	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000109	0.000559	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000109	0.000557	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000108	0.000554	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000108	0.000553	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000108	0.000551	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000105	0.000537	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000105	0.000537	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000105	0.000535	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000105	0.000535	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000104	0.000535	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000104	0.000535	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000104	0.000531	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000104	0.000531	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000103	0.000525	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000102	0.00052	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000102	0.00052	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000102	0.00052	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.97e-05	0.00051	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.92e-05	0.000508	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.89e-05	0.000506	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.84e-05	0.000504	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.82e-05	0.000503	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.77e-05	0.0005	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.54e-05	0.000489	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.54e-05	0.000489	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.48e-05	0.000486	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.34e-05	0.000478	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	9.1e-05	0.000466	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.1e-05	0.000466	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.06e-05	0.000464	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.98e-05	0.00046	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.93e-05	0.000458	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.61e-05	0.000441	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.54e-05	0.000438	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.48e-05	0.000434	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.23e-05	0.000422	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.19e-05	0.000419	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-05	0.000407	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-05	0.000407	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.89e-05	0.000404	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.86e-05	0.000403	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.84e-05	0.000401	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.83e-05	0.000401	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.78e-05	0.000398	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.76e-05	0.000397	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.74e-05	0.000396	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.74e-05	0.000396	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.73e-05	0.000396	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.72e-05	0.000395	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.71e-05	0.000395	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.7e-05	0.000394	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.7e-05	0.000394	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.66e-05	0.000392	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.61e-05	0.00039	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.5e-05	0.000384	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.26e-05	0.000372	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.17e-05	0.000367	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.16e-05	0.000367	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.15e-05	0.000366	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.11e-05	0.000364	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.11e-05	0.000364	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.05e-05	0.000361	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.01e-05	0.000359	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7e-05	0.000359	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.96e-05	0.000357	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.96e-05	0.000356	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.81e-05	0.000349	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.69e-05	0.000342	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.69e-05	0.000342	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.54e-05	0.000335	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.43e-05	0.000329	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.4e-05	0.000328	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.39e-05	0.000327	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.06e-05	0.00031	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.03e-05	0.000309	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.89e-05	0.000302	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.86e-05	0.0003	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.8e-05	0.000297	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.77e-05	0.000296	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.71e-05	0.000293	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.68e-05	0.000291	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.3e-05	0.000272	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.28e-05	0.00027	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.19e-05	0.000266	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.16e-05	0.000264	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.09e-05	0.000261	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.01e-05	0.000257	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.94e-05	0.000253	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.58e-05	0.000235	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.48e-05	0.00023	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-05	0.000212	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-05	0.000212	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.12e-05	0.000211	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.12e-05	0.000211	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.11e-05	0.00021	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.09e-05	0.000209	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.02e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4e-05	0.000205	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.78e-05	0.000194	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.78e-05	0.000193	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.76e-05	0.000193	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.56e-05	0.000182	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.07e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.05e-05	0.000156	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.05e-05	0.000156	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.03e-05	0.000155	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.65e-05	0.000136	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.63e-05	0.000135	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000125	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000125	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000124	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000121	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.22e-05	0.000114	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.8e-05	9.23e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.79e-05	9.18e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.56e-05	7.97e-05	CbGpPWpGaD
